Accessibility
Animation
Accessibility

Video

Non-Alcoholic Steatohepatitis (NASH): Preclinical and Clinical Development and Progress Toward Regulatory Approval Pathways

June 19, 2015
Learn more about the challenges of this "silent" liver disease along with therapeutic strategies to accelerate both clinical and regulatory efforts for this critical unmet medical need.